Access to hematopoietic stem cell transplant for patients with sickle cell anemia

Emily Riehm Meier, Theodore Johnson, Kerice Pinkney, Maria C. Velez, Naynesh Kamani, Isaac Odame

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with phenotypically severe sickle cell anemia, and survival rates following matched-sibling HSCT are very high. However, despite cure rates much higher than HSCT for malignant diseases, the field has been slow to adopt this treatment modality for sickle cell anemia. This article explores some of the social forces that may contribute to this dichotomy.

Original languageEnglish (US)
Article numbere27105
JournalPediatric Blood and Cancer
Volume65
Issue number9
DOIs
StatePublished - Sep 2018

Keywords

  • diversity
  • healthcare disparities
  • hematopoietic stem cell transplant
  • hydroxyurea
  • sickle cell anemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Access to hematopoietic stem cell transplant for patients with sickle cell anemia'. Together they form a unique fingerprint.

  • Cite this